EP
MRTX

Eversept Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Eversept Partners’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,840
Closed -$2.18M – 103
2021
Q4 		$2.18M Buy
14,840
+5,485
+59% +$805K 0.14% 64
2021
Q3 		$1.65M Buy
+9,355
New +$1.65M 0.11% 69